356 related articles for article (PubMed ID: 27537474)
1. Transplantation for thalassemia major: alternative donors.
Locatelli F; Merli P; Strocchio L
Curr Opin Hematol; 2016 Nov; 23(6):515-523. PubMed ID: 27537474
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic Stem Cell Transplantation in Thalassemia.
Strocchio L; Locatelli F
Hematol Oncol Clin North Am; 2018 Apr; 32(2):317-328. PubMed ID: 29458734
[TBL] [Abstract][Full Text] [Related]
3. Matched sibling donor hematopoietic stem cell transplantation for thalassemia.
Issaragrisil S; Kunacheewa C
Curr Opin Hematol; 2016 Nov; 23(6):508-514. PubMed ID: 27518930
[TBL] [Abstract][Full Text] [Related]
4. Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease.
Fitzhugh CD; Abraham A; Hsieh MM
Adv Exp Med Biol; 2017; 1013():123-153. PubMed ID: 29127679
[TBL] [Abstract][Full Text] [Related]
5. Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning Regimen.
Sun L; Wang N; Chen Y; Tang L; Xing C; Lu N; Shi Y; Ma Y; Lin F; Yu K; Feng J
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1592-1596. PubMed ID: 30951841
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic cellular gene therapy for hemoglobinopathies.
Gaziev J; Lucarelli G
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
[TBL] [Abstract][Full Text] [Related]
7. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
Kindwall-Keller TL; Ballen KK
Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.
Bernaudin F; Pondarré C; Galambrun C; Thuret I
Adv Exp Med Biol; 2017; 1013():89-122. PubMed ID: 29127678
[TBL] [Abstract][Full Text] [Related]
9. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
[TBL] [Abstract][Full Text] [Related]
10. Augmented immunosuppression and PTCY-based haploidentical hematopoietic stem cell transplantation for thalassemia major.
Vellaichamy Swaminathan V; Ravichandran N; Ramanan KM; Meena SK; Varla H; Ramakrishnan B; Jayakumar I; Uppuluri R; Raj R
Pediatr Transplant; 2021 Mar; 25(2):e13893. PubMed ID: 33111490
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic Stem Cell Transplantation in Thalassemia.
Algeri M; Lodi M; Locatelli F
Hematol Oncol Clin North Am; 2023 Apr; 37(2):413-432. PubMed ID: 36907612
[TBL] [Abstract][Full Text] [Related]
12. Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathies.
Alfraih F; Aljurf M; Fitzhugh CD; Kassim AA
Semin Hematol; 2016 Apr; 53(2):120-8. PubMed ID: 27000737
[TBL] [Abstract][Full Text] [Related]
13. Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients.
Morishita S; Kaida K; Yamauchi S; Wakasugi T; Ikegame K; Kodama N; Ogawa H; Domen K
Eur J Oncol Nurs; 2015 Oct; 19(5):443-50. PubMed ID: 25911269
[TBL] [Abstract][Full Text] [Related]
14. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation from non-sibling matched family donors for patients with thalassemia major in Jordan.
Hussein AA; Al-Zaben A; Khattab E; Haroun A; Frangoul H
Pediatr Transplant; 2016 Feb; 20(1):120-3. PubMed ID: 26493691
[TBL] [Abstract][Full Text] [Related]
16. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
McCurdy SR; Kasamon YL; Kanakry CG; Bolaños-Meade J; Tsai HL; Showel MM; Kanakry JA; Symons HJ; Gojo I; Smith BD; Bettinotti MP; Matsui WH; Dezern AE; Huff CA; Borrello I; Pratz KW; Gladstone DE; Swinnen LJ; Brodsky RA; Levis MJ; Ambinder RF; Fuchs EJ; Rosner GL; Jones RJ; Luznik L
Haematologica; 2017 Feb; 102(2):391-400. PubMed ID: 27846611
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China.
Li XY; Sun X; Chen J; Qin MQ; Luan Z; Zhu YP; Fang JP
World J Pediatr; 2018 Feb; 14(1):92-99. PubMed ID: 29511925
[TBL] [Abstract][Full Text] [Related]
18. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?
Ruggeri A; Ciceri F; Gluckman E; Labopin M; Rocha V;
Best Pract Res Clin Haematol; 2010 Jun; 23(2):207-16. PubMed ID: 20837332
[TBL] [Abstract][Full Text] [Related]
19. Unrelated donor hematopoietic transplantation.
de Lima M; Champlin R
Rev Clin Exp Hematol; 2001 Jun; 5(2):100-34. PubMed ID: 11486651
[TBL] [Abstract][Full Text] [Related]
20. Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation.
Coquerelle S; Ghardallou M; Rais S; Taupin P; Touzot F; Boquet L; Blanche S; Benaouadi S; Brice T; Tuchmann-Durand C; Ribeil JA; Magrin E; Lissillour E; Rochaix L; Cavazzana M; Durand-Zaleski I
Hum Gene Ther; 2019 Jun; 30(6):753-761. PubMed ID: 30700149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]